Veterinary Oncology Market Growth Forecast With Analysis Of Industry Progress Through 2030

June 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Veterinary Oncology Market By 2030 Based On Its 2026 Value?

The veterinary oncology market has experienced significant expansion recently. Projections indicate it will expand from $0.45 billion in 2025 to reach $0.5 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.0%. Historically, this growth can be ascribed to several factors, including an increased occurrence of cancer in pets, heightened understanding of available veterinary oncology services, innovations in surgical and radiology technologies, the proliferation of veterinary hospitals and specialized clinics, and the wider acceptance of traditional chemotherapy approaches.

The veterinary oncology market is anticipated to experience significant expansion in the coming years. Its value is set to reach $0.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast period stems from factors such as a heightened demand for personalized and targeted treatments, an increase in the adoption of advanced radiology and imaging, a surge in the application of immunotherapy and supportive care, advancements in minimally invasive surgical techniques, and the incorporation of combination chemotherapy and targeted therapy protocols. Key trends expected during this period involve the expansion of targeted and personalized veterinary cancer treatments, an uptake in minimally invasive surgical methods, broader implementation of advanced radiology and imaging technologies, the formulation of combination chemotherapy protocols, and the inclusion of immunotherapy and supportive care within treatment strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Important Drivers Are Powering The Veterinary Oncology Market Growth?

The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body’s cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused on cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the The Cancer Letter, a US-based publication that covers cancer research stated that in 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, November 2023, it’s estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer in their lifetime. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology market.

What Key Segment Areas Are Included In The Veterinary Oncology Market Assessment?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Which Trends Are Affecting The Veterinary Oncology Market Framework?

Major companies operating in the veterinary oncology market are focused on developing neoantigens, which are unique tumor-specific antigens that arise from mutations in cancer cells. Neoantigens are unique protein fragments that arise from tumor-specific mutations in cancer cells. Unlike normal antigens found in healthy tissues, neoantigens are produced as a result of genetic changes (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company launched cancer vaccine trial for dogs. Neoantigens are being explored in the development of cancer vaccines and other immunotherapies, with the goal of enhancing the immune response specifically against cancer cells while sparing normal cells.

Which Firms Are Competing In The Veterinary Oncology Market?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Regional Market Leads The Veterinary Oncology Market?

Access a Customized Veterinary Oncology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on: